. WHO halts malaria drug study, eyes steroid for COVID-19 - IOPAC Press "Enter" to skip to content

New joint health system review highlights opportunities for strengthening health care services for refugees and migrant communities in Uganda.
- All WHO news
<p><img src="https://cdn-auth-cms.who.int/media-aut/images/default-source/health-topics/refugee-and-migrant-health/comms-2/screenshot-5.png?sfvrsn=a6eff582_2" sf-size="2237955" alt="Health and Migrant health system review: challenges and opportunities for long term health system's strengthening in Uganda"...
Parliamentarians unite in Berlin to sign global statement supporting the WHO Pandemic Agreement
- All WHO news
Parliamentarians from across the globe gathered at the UNITE Global Summit in Berlin to sign a statement in support of...
Attacks on hospitals and health workers jeopardize provision of health in Lebanon
- All WHO news
Since the escalation of hostilities between Israel and Lebanon on 17 September 2024, WHO has verified 23 attacks on health...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

WHO halts malaria drug study, eyes steroid for COVID-19

By iopac on June 17, 2020

Lisa Schnirring | News Editor | CIDRAP NewsJun 17, 2020″We need more therapeutics that can be used to tackle the virus.”

Published in COVID-19

iopac